NCT01490931View on ClinicalTrials.gov

Intranasal Ketorolac for Postsurgical Pain in Dental Implant Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Acute Pain
Interventions
DRUG

Ketorolac Nasal Spray

15.75 mg nasal spray delivery to each nostril no more than every six hours

Trial Locations (1)

19104-6030

University of Pennsylvania School of Dental Medicine, Philadelphia

All Listed Sponsors
lead

Hersh, Elliot V., DMD, MS, PhD

INDIV

NCT01490931 - Intranasal Ketorolac for Postsurgical Pain in Dental Implant Patients | Biotech Hunter | Biotech Hunter